Your EP Business Partner

We provide the financing, infrastructure, and operational platform to build your outpatient EP practice from the ground up.

More than an MSO

We are building the nation’s first network of healthcare centers dedicated to treating Afib and other cardiac arrhythmias. Partnering with world-class Electrophysiologists, we’re making independed EP practice the standard model of care. 

Nurse-Led Clinics

Trained clinical teams manage Afib patient populations, risk-factor management, and longitudinal care coordination – creating a consistent procedural pipeline. 

Outpatient EP Procedures

CMS-approved ASCs designed for outpatient cardiac ablation, including pulsed-field ablation (PFA). Lower overhead, better patient experience. Fully equipped to maximize patient access. 

The EP at the Center

The electrophysiologist is the hub. Every operational decision – staffing, scheduling, technology, marketing – is made to protect your time, extend your reach, and give you practice autonomy. 

Our Services

Current Clinic provides the full infrastructure of an independent EP practice so you don’t have to piece it together yourself. 

Practice Financing & Capital

Clinic & ASC Buildout

Payor Contracting & Negotiation

Daily Operations & Workflows

Technology Implimentation

Staffing & Recruiting

Billing & Revenue Cycle Management

Market Development

Patient Acquisition

Clinical Trial Administration

Travel Coordination & Logistics

Business & Thought Partnership

EP Care is Changing

The EP and Afib market has changed. Between updated guidelines, regulatory transformation, and advancements in procedural technology, the future of EP care is outpatient.

Care Guidelines

In 2023, ACC/AHA/ACCP/HRS guidelines elevated catheter ablation to a Class I first-line recommendation for Afib. 

Regulatory Transformation

In January 2026, CMS added cardiac catheter ablation to the ASC covered procedures list, a landmark shift that makes outpatient EP practice economically viable.

Ablation Technology

Pulsed-Field Ablation continues to emerge as the preferred modality for EP intervention, with clinical evidence now suggesting considerably better outcomes than AADs alone.